950 related articles for article (PubMed ID: 17705522)
1. Comparative profiling of serum glycoproteome by sequential purification of glycoproteins and 2-nitrobenzensulfenyl (NBS) stable isotope labeling: a new approach for the novel biomarker discovery for cancer.
Ueda K; Katagiri T; Shimada T; Irie S; Sato TA; Nakamura Y; Daigo Y
J Proteome Res; 2007 Sep; 6(9):3475-83. PubMed ID: 17705522
[TBL] [Abstract][Full Text] [Related]
2. Comparative serum glycoproteomics using lectin selected sialic acid glycoproteins with mass spectrometric analysis: application to pancreatic cancer serum.
Zhao J; Simeone DM; Heidt D; Anderson MA; Lubman DM
J Proteome Res; 2006 Jul; 5(7):1792-802. PubMed ID: 16823988
[TBL] [Abstract][Full Text] [Related]
3. A strategy for discovery of cancer glyco-biomarkers in serum using newly developed technologies for glycoproteomics.
Narimatsu H; Sawaki H; Kuno A; Kaji H; Ito H; Ikehara Y
FEBS J; 2010 Jan; 277(1):95-105. PubMed ID: 19919546
[TBL] [Abstract][Full Text] [Related]
4. Glycoproteomic analysis of WGA-bound glycoprotein biomarkers in sera from patients with lung adenocarcinoma.
Hongsachart P; Huang-Liu R; Sinchaikul S; Pan FM; Phutrakul S; Chuang YM; Yu CJ; Chen ST
Electrophoresis; 2009 Apr; 30(7):1206-20. PubMed ID: 19294700
[TBL] [Abstract][Full Text] [Related]
5. Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS.
Heo SH; Lee SJ; Ryoo HM; Park JY; Cho JY
Proteomics; 2007 Dec; 7(23):4292-302. PubMed ID: 17963278
[TBL] [Abstract][Full Text] [Related]
6. Derivatized cellulose combined with MALDI-TOF MS: a new tool for serum protein profiling.
Feuerstein I; Rainer M; Bernardo K; Stecher G; Huck CW; Kofler K; Pelzer A; Horninger W; Klocker H; Bartsch G; Bonn GK
J Proteome Res; 2005; 4(6):2320-6. PubMed ID: 16335981
[TBL] [Abstract][Full Text] [Related]
7. Chemical methods for glycoprotein discovery.
Bond MR; Kohler JJ
Curr Opin Chem Biol; 2007 Feb; 11(1):52-8. PubMed ID: 17174139
[TBL] [Abstract][Full Text] [Related]
8. Targeted serum glycoproteomics for the discovery of lung cancer-associated glycosylation disorders using lectin-coupled ProteinChip arrays.
Ueda K; Fukase Y; Katagiri T; Ishikawa N; Irie S; Sato TA; Ito H; Nakayama H; Miyagi Y; Tsuchiya E; Kohno N; Shiwa M; Nakamura Y; Daigo Y
Proteomics; 2009 Apr; 9(8):2182-92. PubMed ID: 19322776
[TBL] [Abstract][Full Text] [Related]
9. A glycomics approach to the discovery of potential cancer biomarkers.
An HJ; Lebrilla CB
Methods Mol Biol; 2010; 600():199-213. PubMed ID: 19882130
[TBL] [Abstract][Full Text] [Related]
10. N-linked glycosylation profiling of pancreatic cancer serum using capillary liquid phase separation coupled with mass spectrometric analysis.
Zhao J; Qiu W; Simeone DM; Lubman DM
J Proteome Res; 2007 Mar; 6(3):1126-38. PubMed ID: 17249709
[TBL] [Abstract][Full Text] [Related]
11. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
Yu KH; Rustgi AK; Blair IA
J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
[TBL] [Abstract][Full Text] [Related]
12. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
Fiedler GM; Leichtle AB; Kase J; Baumann S; Ceglarek U; Felix K; Conrad T; Witzigmann H; Weimann A; Schütte C; Hauss J; Büchler M; Thiery J
Clin Cancer Res; 2009 Jun; 15(11):3812-9. PubMed ID: 19470732
[TBL] [Abstract][Full Text] [Related]
13. Clinical proteomics in breast cancer: a review.
Gast MC; Schellens JH; Beijnen JH
Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
[TBL] [Abstract][Full Text] [Related]
14. Application of targeted quantitative proteomics analysis in human cerebrospinal fluid using a liquid chromatography matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometer (LC MALDI TOF/TOF) platform.
Pan S; Rush J; Peskind ER; Galasko D; Chung K; Quinn J; Jankovic J; Leverenz JB; Zabetian C; Pan C; Wang Y; Oh JH; Gao J; Zhang J; Montine T; Zhang J
J Proteome Res; 2008 Feb; 7(2):720-30. PubMed ID: 18186601
[TBL] [Abstract][Full Text] [Related]
15. Screening of glycosylation patterns in serum using natural glycoprotein microarrays and multi-lectin fluorescence detection.
Patwa TH; Zhao J; Anderson MA; Simeone DM; Lubman DM
Anal Chem; 2006 Sep; 78(18):6411-21. PubMed ID: 16970316
[TBL] [Abstract][Full Text] [Related]
16. Global and targeted quantitative proteomics for biomarker discovery.
Veenstra TD
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):3-11. PubMed ID: 17023222
[TBL] [Abstract][Full Text] [Related]
17. Proteomics in the diagnosis of hepatocellular carcinoma: focus on high risk hepatitis B and C patients.
El-Aneed A; Banoub J
Anticancer Res; 2006; 26(5A):3293-300. PubMed ID: 17094443
[TBL] [Abstract][Full Text] [Related]
18. Novel comprehensive approach for accessible biomarker identification and absolute quantification from precious human tissues.
Turtoi A; Dumont B; Greffe Y; Blomme A; Mazzucchelli G; Delvenne P; Mutijima EN; Lifrange E; De Pauw E; Castronovo V
J Proteome Res; 2011 Jul; 10(7):3160-82. PubMed ID: 21534635
[TBL] [Abstract][Full Text] [Related]
19. Specific MALDI imaging and profiling for biomarker hunting and validation: fragment of the 11S proteasome activator complex, Reg alpha fragment, is a new potential ovary cancer biomarker.
Lemaire R; Menguellet SA; Stauber J; Marchaudon V; Lucot JP; Collinet P; Farine MO; Vinatier D; Day R; Ducoroy P; Salzet M; Fournier I
J Proteome Res; 2007 Nov; 6(11):4127-34. PubMed ID: 17939699
[TBL] [Abstract][Full Text] [Related]
20. Identification of accessible human cancer biomarkers using ex vivo chemical proteomic strategies.
Kischel P; Waltregny D; Castronovo V
Expert Rev Proteomics; 2007 Dec; 4(6):727-39. PubMed ID: 18067412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
